1293P Mechanisms of resistance to selpercatinib in RET activated NSCLC and MTC from the LIBRETTO-001 trial
B.J. Solomon(Peter MacCallum Cancer Centre), M.E. Cabanillas(The University of Texas MD Anderson Cancer Center), Ashish C. Massey(Albert Einstein College of Medicine), Xi Rao(Indiana University School of Medicine), Anna M. Szpurka(Eli Lilly (United States)), Hyung Jin Won(Eli Lilly (United States)), L.J. Wirth(Massachusetts General Hospital), Jean L. Wright(University of North Carolina at Chapel Hill), S. G. Barker(Eli Lilly (United States)), A.E. Drilon(Memorial Sloan Kettering Cancer Center)
Cited by 1
Related Papers
Radiation therapy for the whole breast: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline
|Practical Radiation Oncology|2018|615
Effectiveness of early orthodontic treatment with the twin-block appliance: A multicenter, randomized, controlled trial. Part 1: Dental and skeletal effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|374
Effectiveness of treatment for class II malocclusion with the herbst or twin-block appliances: a randomized, controlled trial
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|275
Effectiveness of early orthodontic treatment with the twin-block appliance: a multicenter, randomized, controlled trial. Part 2: psychosocial effects
|American Journal of Orthodontics and Dentofacial Orthopedics|2003|191
Early treatment for Class II Division 1 malocclusion with the Twin-block appliance: A multi-center, randomized, controlled trial
|American Journal of Orthodontics and Dentofacial Orthopedics|2009|169